Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (10): 960-961.DOI: 10.3969/j.issn.1673-8640.2019.10.022
Previous Articles Next Articles
Received:2018-08-10
Online:2019-10-30
Published:2019-11-01
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.10.022
| [1] | 贝佳露,付强,张薏. 妊娠合并骨髓增生异常综合征的诊治进展[J]. 现代妇产科进展,2015,24(9):714-715. |
| [2] | 刘家希,王化泉. 骨髓增生异常综合征诊断和治疗进展[J]. 中国癌症防治杂志,2017,9(2):158-163. |
| [3] | 常春康. 骨髓增生异常综合征WHO(2016)分型的修正[J]. 诊断学理论与实践,2016,15(3):222-225. |
| [4] | 肖志坚. 骨髓增生异常综合征的精准诊断与治疗:现况与问题[J]. 临床血液学杂志,2017,30(3):339-341. |
| [5] | 唐旭东,张路,刘锋. 治疗骨髓增生异常综合征的药物介绍:第56届美国血液学会年会报道[J]. 白血病·淋巴瘤,2015,24(2):88-90. |
| [6] | 刘淳,汪昭葵,钟慧萍. 妊娠合并骨髓增生异常综合征11例分析[J]. 现代妇产科进展,2007,16(12):927-930. |
| [7] | 钱旭芳,李云云,陈云琴. 妊娠合并骨髓增殖异常综合征的诊治[J]. 中国妇幼保健,2008,26:3659-3661. |
| [8] | YANG Z,MEIYING L,SHANMI W,et al.Pregnancy and myelodysplastic syndrome:an analysis of the clinical characteristics,maternal and fetal outcomes[J]. J Matern Fetal Neonatal Med,2014,28(18):2155-2159. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
